Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
29-Aug-2022
Annual Report to June 30 2022
29-Aug-2022
Preliminary Final Report
29-Aug-2022
Appendix 4G and Corporate Governance Statement
2-Aug-2022
Nyrada Board Changes
2-Aug-2022
Initial Director's Interest Notice - GM
2-Aug-2022
Final Director's Interest Notice - PM
26-Jul-2022
Quarterly Activities Report and Appendix 4C
20-Jul-2022
Nyrada PCSK9 Inhibitor Tested in Model of Atherosclerosis
29-Jun-2022
Cholesterol-Lowering Program Update
7-Jun-2022
Corporate Presentation
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Next